MHC Class II molecules are integral to the adaptive immune response, serving as specialised antigen-presenting proteins on the surface of professional antigen-presenting cells. They bind peptide ...
MHC class II molecules are central to the adaptive immune response, serving as the means by which antigen-presenting cells, notably dendritic cells, display processed peptides to CD4+ T cells. This ...
Which came first, MHC class I or MHC class II? For decades, it has been debated which of these two similar classes came first in evolution. Now, Keiichiro Hashimoto and his group at Fujita Health ...
The study, according to the researchers, is the first to demonstrate the potential use of major histocompatibility complex class II (MHC-II) expression as a predictor of immunotherapy response in ...
Analysis of everolimus starting dose as prognostic marker in HR+ mBC patients treated with everolimus (EVE) + exemestane (EXE): Results of the 3rd interim analysis of the non-interventional trial ...
Prostate Cancer Screening and the Goldilocks Principle: How Much Is Just Right? In this study, we assessed the possible predictive value of 9p24.1/PD-L1/PD-L2 genetic alterations and PD-L1 expression ...
MHC class II transactivator CIITA induces cell resistance to Ebola Virus and SARS-like coronaviruses
August 27, 2020 (Seattle, Wash.)--Discoveries from the Benaroya Research Institute at Virginia Mason (BRI) have identified a new cellular protection pathway that targets a common vulnerability in ...
Maurizio Chiriva-Internati, Fabio Grizzi, Justin Pinkston, K. John Morrow, Nicholas D'Cunha, Eldo E. Frezza, Pier Carlo Muzzio, W. Martin Kast, Everardo Cobos In ...
The chicken major histocompatibility complex (chicken MHC or B complex), at present the most extensively characterized non-mammalian MHC, differes from its human and rodent counterparts in its overall ...
A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine ...
As consolidation therapy for acute myeloid leukemia (AML), allogeneic hematopoietic stem-cell transplantation provides a benefit in part by means of an immune-mediated graft-versus-leukemia effect. We ...
ProImmune launches ProVE SL self-loading MHC Class I monomers to improve T cell research flexibility
ProImmune launches ProVE SL self-loading MHC Class I monomers to improve T cell research flexibility: Oxford, England Saturday, November 1, 2025, 14:00 Hrs [IST] ProImmune Ltd, a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback